Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis"

Comment

Dominique Talabot-Ayer et al. Joint Bone Spine. 2013 Jan.

. 2013 Jan;80(1):117-8.

doi: 10.1016/j.jbspin.2012.10.007. Epub 2012 Nov 20.

No abstract available

Comment on

Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
Talabot-Ayer D, McKee T, Gindre P, Bas S, Baeten DL, Gabay C, Palmer G. Talabot-Ayer D, et al. Joint Bone Spine. 2012 Jan;79(1):32-7. doi: 10.1016/j.jbspin.2011.02.011. Epub 2011 Mar 26. Joint Bone Spine. 2012. PMID: 21441054
Therapeutic potential of IL-33 in rheumatoid arthritis: a comment about the article by Talabot-Ayer D, et al., "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis", Joint Bone Spine 2012;79:32-7.
Xie Q, Wang SC, Zhong J, Li J. Xie Q, et al. Joint Bone Spine. 2013 Jan;80(1):116-7. doi: 10.1016/j.jbspin.2012.10.014. Epub 2012 Dec 11. Joint Bone Spine. 2013. PMID: 23237993 No abstract available.